Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
about
Sensitivity of Dendritic Cells to Microenvironment SignalsAntigenicity and immunogenicity of allogeneic retinal transplantsNK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivityImmunogenicity of unprocessed and photooxidized bovine and human osteochondral grafts in collagen-sensitive miceRoles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease.Immunology of naturally transmissible tumours.Recent developments in the pharmacological treatment and prevention of corneal graft rejection.Antigen location contributes to the pathological features of a transplanted heart graft.The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.Mixed chimerism and split tolerance: mechanisms and clinical correlations.Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox.Contribution of direct and indirect recognition pathways to T cell alloreactivity.Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts.Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.Dendritic cells as promoters of transplant tolerance.Extracellular matrix-based biomaterial scaffolds and the host response.Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants.Exosomes: The missing link between microchimerism and acquired tolerance?T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis.Indirect recognition of donor HLA-DR peptides in organ allograft rejection.T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice.Mechanism of cellular rejection in transplantationDonor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantationAutologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Natural killer cells in rejection and tolerance of solid organ allograftsLoss of tolerance to self after transplant.Immune recognition and rejection of allogeneic skin grafts.Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse.The role of MHC genes in contagious cancer: the story of Tasmanian devils.Mechanisms of oral tolerance by MHC peptides.New approaches to specific immunomodulation in transplantation.T cell receptor (TCR) repertoire in alloimmune responses.Role of indirect allorecognition in allograft rejection.The contribution of peptides to T cell allorecognition and allograft rejection.Indirect T cell recognition in allograft rejection.The role of polymorphic donor peptides in allograft recognition and rejection.Suppression of the indirect pathway of T cell reactivity by high doses of allopeptide.
P2860
Q26752817-75944036-35B3-429E-9A50-1F71962A483BQ28361839-F8805372-42A3-4D85-A0DE-53906B80A296Q30501692-49297522-DA61-4206-A34A-9B9D869AE9F5Q33236890-4FF6C253-311C-420A-AB17-971C78A2873FQ33896432-2417BA4F-C3CE-444E-A07D-151854B047C9Q34041901-6B584BDD-7732-46FB-A0F4-155A6CAB090FQ35040789-1B1788B7-42D3-4B16-AC85-7092D68E66B7Q35097465-6203DD1D-6503-467A-95D3-C2BA5900436BQ35655762-BB55ABE3-A076-4BF9-833D-5F33E7AC15B4Q35691658-4099F1B6-5A7A-40A2-A145-735C343CA145Q35877027-5A8B30B7-70C9-496A-8D1A-B0F6797F9AC5Q36235319-1E43A0BE-5807-4740-A855-A6013DBEA5BFQ36361819-DC83A6E5-5D5A-45D4-A171-5D923902A09EQ36363031-3F846D4C-2AE5-4707-BC61-1F533EF070AEQ36401207-5DD95E4D-7109-4C78-ABC0-CCC6CFD901EEQ36425922-220E6497-3575-4675-8C73-374C39DA61F8Q36669532-0797F6F4-B73E-4431-98CF-65DDC425FAD2Q37119943-D3D7EB77-9A3C-4628-BD48-26257143BA21Q37232364-F367B4CC-8C8A-4E5D-BF17-8AB3A4624295Q37337117-D13F7FB3-21C0-4D3C-97A5-D064F89F2D25Q37356001-1CC56BDD-39DE-4909-BE0A-D30D660B9934Q37359225-B173DBCF-D060-4DD9-A9DE-F95E2FDE9C46Q37379596-663CDE41-5B3C-475E-B031-D92FE3021A86Q37424651-18B69461-8508-4D00-83AD-EE5D58697375Q37482027-987C60BE-58D1-4478-9242-5EEF83528D8DQ37528715-204BEC46-C048-47E0-991B-46BD22399A2BQ37820879-5FE2E67F-F22F-4906-86D1-BCD6F2EF63D5Q37836540-064BF013-645B-4EB9-BE16-F3A39FA4E274Q37888686-8418AABE-6B5B-4554-9D1A-222D83230C0CQ38772141-250ED005-07D0-48C4-865A-4E4B5BAE3D1AQ39140007-BA20611C-EC8F-4ED0-9FAA-FEC55375F228Q39427595-3040CCC4-AA8F-4A6A-8E3A-B4C813E18B79Q40976397-8B39A505-F7D7-4358-9BC2-25C79D201D6AQ41091885-51F5182F-3D7E-4005-A26D-D91ABB67138EQ41091894-641C3729-260F-480F-B9E6-7CEBE75D6A24Q41091908-3CF637D2-675D-41CA-A401-5AE55D9AE9DAQ41091913-2BEE39A4-6BAC-4638-B3D4-55C6B10EDE8BQ41091920-A0DAC283-A52C-4027-9770-7F5A067725FFQ41349724-67104FDF-0B0B-44EE-A941-9979BAB786BAQ41384611-6B16C15B-9E24-4556-A09E-150494B1655F
P2860
Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Donor major histocompatibility ...... ecules during graft rejection.
@ast
Donor major histocompatibility ...... ecules during graft rejection.
@en
type
label
Donor major histocompatibility ...... ecules during graft rejection.
@ast
Donor major histocompatibility ...... ecules during graft rejection.
@en
prefLabel
Donor major histocompatibility ...... ecules during graft rejection.
@ast
Donor major histocompatibility ...... ecules during graft rejection.
@en
P2093
P2860
P356
P1476
Donor major histocompatibility ...... ecules during graft rejection.
@en
P2093
E E Sercarz
G Benichou
M McMillan
P A Takizawa
P2860
P304
P356
10.1084/JEM.175.1.305
P407
P577
1992-01-01T00:00:00Z